Skip to main content
. 2017 Feb 11;8(13):20612–20621. doi: 10.18632/oncotarget.15296

Table 1. Candidate genes and candidate epistatic variants.

Gene ID Effect Proposed Interaction Reference
APOA1 rs670 Deleterious Buffered Garasto et al., 2003 [45]
APOE APOEε4 Deleterious APOEε4 buffered by HP1/1 Napolioni et al., 2011 [44]
HFE rs1800562 Deleterious HFE T allele buffered Tan et al., 2003 [24]
KL rs9536314 Deleterious KL het buffered Bergman et al., 2007 [7]
LPA(1) rs1853021 Deleterious LPA het buffered by CETP VV Bergman et al., 2007 [7]
LPA(2) rs3798220 Deleterious Risk for coronary disease Clarke et al., 2009 [22]
LPA(3) rs10455872 Deleterious Risk for coronary disease Clarke et al., 2009 [22]
MTTP rs2866164 Deleterious MTTP CC buffered by APOC3 CC, CETP VV, ADIPOQ del/del Huffman et al., 2012 [46]
PON1 rs662 Deleterious PON1 het buffered Bonafè et al., 2002 [47]
ADIPOQ rs56354395 Protective ADIPOQ del/del buffers MTTP CC Atzmon et al., 2008 [27]
APOC3 rs595049 (LD with rs2542052) Protective APOC3 CC buffers MTTP CC Atzmon et al., 2006 [48]
CETP rs5882 Protective CETP VV buffers MTTP CC, LPA(1) het Barzilai et al., 2003 [29]
CRYL1 rs7989332 Protective AD-associated with KHDRBS2 Gusareva et al., 2014 [15]
FOXO1 rs2701858 Protective Joint effect with FOXO3(1) for longevity Tan et al., 2013 [49]
FOXO3(1) rs9486902 Protective Joint effect with FOXO1 for longevity Tan et al., 2013 [49]
FOXO3(2) rs2802292 Protective FOXO3 GG buffering Willcox et al., 2008 [20]
HP rs72294371 Protective HP1/1 buffers APOEε4 Napolioni et al., 2011 [44]
KHDRBS2 rs6455128 Protective AD-associated with CRYL1 Gusareva et al., 2014 [15]

Effect indicates whether the variant was considered be deleterious or protective in the original literature report. Het = heterozygous, AD = Alzheimer's disease.